Clinical Trial

Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes

Study acronym: FeMIC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the trial is to investigate the effect of fecal microbiota transplantation versus placebo on glycemic metabolism and gut microbiota composition in people with type 2 diabetes.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-30
minor Completion pushed: 2026-09 -> 2026-10-15 2026-04-30
notable Primary completion pushed: 2026-04 -> 2026-06-25 2026-04-09
Trial Details
NCT Number NCT07375797
Lead Sponsor Central Jutland Regional Hospital
Collaborators: Aarhus University Hospital, University of Aarhus
Conditions Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test, Continuous Glucose Monitoring
Enrollment 16 participants
Start Date 2026-02-05
Primary Completion 2026-06-25 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-14